199 related articles for article (PubMed ID: 25809795)
1. High nevus counts confer a favorable prognosis in melanoma patients.
Ribero S; Davies JR; Requena C; Carrera C; Glass D; Rull R; Vidal-Sicart S; Vilalta A; Alos L; Soriano V; Quaglino P; Traves V; Newton-Bishop JA; Nagore E; Malvehy J; Puig S; Bataille V
Int J Cancer; 2015 Oct; 137(7):1691-8. PubMed ID: 25809795
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with de novo versus nevus-associated melanoma.
Lin WM; Luo S; Muzikansky A; Lobo AZ; Tanabe KK; Sober AJ; Cosimi AB; Tsao H; Duncan LM
J Am Acad Dermatol; 2015 Jan; 72(1):54-8. PubMed ID: 25440436
[TBL] [Abstract][Full Text] [Related]
3. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
4. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
6. Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
Geller AC; Mayer JE; Sober AJ; Miller DR; Argenziano G; Johnson TM; Swetter SM
JAMA Dermatol; 2016 Apr; 152(4):413-8. PubMed ID: 26934430
[TBL] [Abstract][Full Text] [Related]
7. Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.
Hanks JE; Kovatch KJ; Ali SA; Roberts E; Durham AB; Smith JD; Bradford CR; Malloy KM; Boonstra PS; Lao CD; McLean SA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):520-529. PubMed ID: 32041486
[TBL] [Abstract][Full Text] [Related]
8. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
[TBL] [Abstract][Full Text] [Related]
9. [Sentinel lymph node biopsy in patients with melanoma].
Tomás-Mallebrera L; Rojo-España R; Marquina-Vila A; Gimeno-Clemente N; Morales-Suárez-Varela MM
Actas Dermosifiliogr; 2010 Jun; 101(5):428-36. PubMed ID: 20525486
[TBL] [Abstract][Full Text] [Related]
10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and survival data of melanoma patients with nevus cell aggregates within sentinel lymph nodes.
Gambichler T; Scholl L; Stücker M; Bechara FG; Hoffmann K; Altmeyer P; Othlinghaus N
Am J Clin Pathol; 2013 May; 139(5):566-73. PubMed ID: 23596107
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of SLN benign capsular nevi in patients with melanoma.
Yamashita TS; Pockaj BA; Bagaria SP; Flotte TJ; Fahy AS; de Azevedo RU; Harmsen WS; Block MS; Jakub JW
J Surg Oncol; 2020 Nov; 122(6):1043-1049. PubMed ID: 33616952
[TBL] [Abstract][Full Text] [Related]
13. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
14. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
Gutzmer R; Satzger I; Thoms KM; Völker B; Mitteldorf C; Kapp A; Bertsch HP; Kretschmer L
J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216
[TBL] [Abstract][Full Text] [Related]
16. Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.
Tejera-Vaquerizo A; Nagore E; Puig S; Robert C; Saiag P; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Aguilera J; Malvehy J; Carrera C; Cavalcanti A; Rull R; Vilalta-Solsona A; Lannoy E; Boutros C; Benannoune N; Tomasic G; Aegerte P; Vidal-Sicart S; Palou J; Alos LL; Requena C; Traves V; Pla Á; Bolumar I; Soriano V; Guillén C; Herrera-Ceballos E
Eur J Cancer; 2015 Sep; 51(13):1780-93. PubMed ID: 26072362
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous melanoma: correlation between clinical and histologic aspects in a retrospective Italian study.
Cozzani E; Cecchi F; Ghigliotti G; Tavilla P; Cabiddu F; Drago F; Burlando M; Rongioletti F; Parodi A
G Ital Dermatol Venereol; 2019 Oct; 154(5):519-522. PubMed ID: 31638350
[TBL] [Abstract][Full Text] [Related]
18. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
[TBL] [Abstract][Full Text] [Related]
20. Nevi and Breslow thickness in melanoma: sex differences?
De Giorgi V; Scarfì F; Gori A; Maida P; Trane L; Silvestri F; Portelli F; Massi D; Covarelli P; Gandini S
Melanoma Res; 2020 Apr; 30(2):179-184. PubMed ID: 31574530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]